Bettelli, Alice; Ruggiano, Rita; Bocchi, Silvia; Rocchi, Laura; Faenza, Andrea; Borsi, Enrica; Terragna, Carolina; Zamagni, Elena; Martello, Marina; Bettelli, Marco; Rambelli, Laura; Guadagnuolo, Viviana; Pecorari, Nicola; Giulianelli, Luca; Pisani, Matteo; Biscarini, Dario; Cavo, Michele; Guerrieri, Roberto; Bocchi, Massimo, Inter-Cell Networking Profiling Enables Comprehensive Characterization of Immune-Mediated Activity of Anti-CD38 Therapy through Ex-Vivo Analysis of Multiple Myeloma Patients, in: American Society of Hematology, Blood, Washington, DC, American Society of Hematology, 2019, 134, pp. 3372 - 3372 (atti di: 61th ASH Annual Meeting, Booth 971, Orange County Convention Center (OCCC), Orlando, FL, December 7 - 10, 2019) [Contributo in Atti di convegno]
Hillengass, Jens; Usmani, Saad; Rajkumar, S Vincent; Durie, Brian G M; Mateos, María-Victoria; Lonial, Sagar; Joao, Cristina; Anderson, Kenneth C; García-Sanz, Ramón; Riva, Eloísa; Du, Juan; van de Donk, Niels; Berdeja, Jesús G; Terpos, Evangelos; Zamagni, Elena; Kyle, Robert A; San Miguel, Jesús; Goldschmidt, Hartmut; Giralt, Sergio; Kumar, Shaji; Raje, Noopur; Ludwig, Heinz; Ocio, Enrique; Schots, Rik; Einsele, Hermann; Schjesvold, Fredrik; Chen, Wen-Ming; Abildgaard, Niels; Lipe, Brea C; Dytfeld, Dominik; Wirk, Baldeep Mona; Drake, Matthew; Cavo, Michele; Lahuerta, Juan José; Lentzsch, Suzanne, International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders, «THE LANCET ONCOLOGY», 2019, 20, pp. 302 - 312 [articolo]
Bonifazi, Francesca; Dan, Elisa; Labopin, Myriam; Sessa, Mariarosaria; Guadagnuolo, Viviana; Ferioli, Martina; Rizzi, Simonetta; De Carolis, Sabrina; Sinigaglia, Barbara; Motta, Maria Rosa; Bontadini, Andrea; Giudice, Valeria; Martinelli, Giovanni; Arpinati, Mario; Cavo, Michele; Bonafé, Massimiliano; Storci, Gianluca, Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study, «BONE MARROW TRANSPLANTATION», 2019, 54, pp. 717 - 725 [articolo]Open Access
Attal, Michel; Richardson, Paul G; Rajkumar, S Vincent; San-Miguel, Jesus; Beksac, Meral; Spicka, Ivan; Leleu, Xavier; Schjesvold, Fredrik; Moreau, Philippe; Dimopoulos, Meletios A; Huang, Jeffrey Shang-Yi; Minarik, Jiri; Cavo, Michele; Prince, H Miles; Macé, Sandrine; Corzo, Kathryn P; Campana, Frank; Le-Guennec, Solenn; Dubin, Franck; Anderson, Kenneth C; ICARIA-MM study, Group, Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study, «THE LANCET», 2019, 394, pp. 2096 - 2107 [articolo]
Antonio, Colecchia; Federico, Ravaioli; Mariarosaria, Sessa; Vanessa, Alemanni Luigina; Elton, Dajti; Giovanni, Marasco; Amanda, Vestito; Maurizio, Zagari Rocco; Barbato, Francesco; Mario, Arpinati; Michele, Cavo; Davide, Festi; Francesca, Bonifazi, Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study, «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2019, 25, pp. 995 - 1003 [articolo]Open Access
Girmenia, Corrado; Cavo, Michele; Offidani, Massimo; Scaglione, Francesco; Corso, Alessandro; Di Raimondo, Francesco; Musto, Pellegrino; Petrucci, Maria Teresa; Barosi, Giovanni, Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations, «BLOOD REVIEWS», 2019, 34, pp. 84 - 94 [articolo]
Bavaro, Luana; Martelli, Margherita; Cavo, Michele; Soverini, Simona, Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2019, 20, pp. 6141 - 6164 [articolo]Open Access
Gambella, Manuela; Omedé, Paola; Spada, Stefano; Muccio, Vittorio Emanuele; Gilestro, Milena; Saraci, Elona; Grammatico, Sara; Larocca, Alessandra; Conticello, Concetta; Bernardini, Annalisa; Gamberi, Barbara; Troia, Rossella; Liberati, Anna Marina; Offidani, Massimo; Rocci, Alberto; Palumbo, Antonio; Cavo, Michele; Sonneveld, Pieter; Boccadoro, Mario; Oliva, Stefania, Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis, «CANCER», 2019, 125, pp. 750 - 760 [articolo]
Bringhen, Sara; Mina, Roberto; Petrucci, Maria Teresa; Gaidano, Gianluca; Ballanti, Stelvio; Musto, Pellegrino; Offidani, Massimo; Spada, Stefano; Benevolo, Giulia; Ponticelli, Elena; Galieni, Piero; Cavo, Michele; Di Toritto, Tommaso Caravita; Di Raimondo, Francesco; Montefusco, Vittorio; Palumbo, Antonio; Boccadoro, Mario; Larocca, Alessandra, Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies, «HAEMATOLOGICA», 2019, 104, pp. 1640 - 1647 [articolo]Open Access
Dimopoulos MA1, Gay F2, Schjesvold F3, Beksac M4, Hajek R5, Weisel KC6, Goldschmidt H7, Maisnar V8, Moreau P9, Min CK10, Pluta A11, Chng WJ12, Kaiser M13, Zweegman S14, Mateos MV15, Spencer A16, Iida S17, Morgan G18, Suryanarayan K19, Teng Z19, Skacel T19, Palumbo A20, Dash AB19, Gupta N19, Labotka R19, Rajkumar SV21; TOURMALINE-MM3 study group.
Bar D, Basso A, Fantl D, He S, Horvath N, Lee C, Rowlings P, Taylor K, Spencer A, Cochrane T, Kwok F, Ramanathan S, Agis H, Zojer N, Kentos A, Offner F, Van Droogenbroeck J, Wu KL, Maiolino A, Martinez G, Zanella K, Capra M, Araújo S, Gregora E, Hajek R, Maisnar V, Pour L, Scudla V, Spicka I, Abildgaard N, Andersen N, Jensen BA, Helleberg C, Plesner T, Salomo M, Svirskaite A, Delarue R, Moreau P, Blau I, Goldschmidt H, Schieferdecker A, Teleanu V, Munder M, Röllig C, Salwender HJ, Fuhrmann S, Weisel K, Duerig J, Zeis M, Klein S, Reimer P, Schmidt C, Scheid C, Mayer K, Hoffmann M, Sosada M, Dimopoulos A, Delimpasi S, Kyrtsonis MC, Anagnostop, Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial, «THE LANCET», 2019, 393, pp. 253 - 264 [articolo]
Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Pellegrini, Cinzia; Marangon, Miriam; Morigi, Alice; Nanni, Laura; Lolli, Ginevra; Carella, Matteo; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi, PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series, «HAEMATOLOGICA», 2019, 104, pp. e521 - e522 [articolo]Open Access
Usmani SZ1, Schjesvold F2, Oriol A3, Karlin L4, Cavo M5, Rifkin RM6, Yimer HA7, LeBlanc R8, Takezako N9, McCroskey RD10, Lim ABM11, Suzuki K12, Kosugi H13, Grigoriadis G14, Avivi I15, Facon T16, Jagannath S17, Lonial S18, Ghori RU19, Farooqui MZH19, Marinello P19, San-Miguel J20; KEYNOTE-185 Investigators.
Lim A, Grigoriadis G, Walker T, Nicol A, LeBlanc R, Reece D, Elemary M, Boudreault Pedneault JS, Karlin L, Facon T, Attal M, Weisel K, Engelhardt M, Mackensen A, Quinn J, Avivi I, Cohen A, Magen-Nativ H, Benyamini N, Cavo M, Larocca A, Takezako N, Suzuki K, Kosugi H, Matsumoto M, Iida S, Ishikawa T, Kondo Y, Sunami K, Ando K, Teshima T, Chou T, Iwasaki H, Miki H, Matsumura I, Onishi Y, Izutsu K, Kizaki M, George A, Blacklock H, Simpson D, Schjesvold F, Waage A, Samoilova O, Nikitin E, Chagorova T, McDonald A, Patel M, Oriol Rocafiguera A, San Miguel Izquierdo J, Mateos M, Streetly M, Forsyth P, Jackson G, Jenkins S, Rifkin R, Yimer H, McCroskey R, Martincic D, Tarantolo S, Larson S, Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 6, pp. 448 - 458 [articolo]
Usmani SZ1, Schjesvold F2, Oriol A3, Karlin L4, Cavo M5, Rifkin RM6, Yimer HA7, LeBlanc R8, Takezako N9, McCroskey RD10, Lim ABM11, Suzuki K12, Kosugi H13, Grigoriadis G14, Avivi I15, Facon T16, Jagannath S17, Lonial S18, Ghori RU19, Farooqui MZH19, Marinello P19, San-Miguel J20; KEYNOTE-185 Investigators.
Lim A, Grigoriadis G, Walker T, Nicol A, LeBlanc R, Reece D, Elemary M, Boudreault Pedneault JS, Karlin L, Facon T, Attal M, Weisel K, Engelhardt M, Mackensen A, Quinn J, Avivi I, Cohen A, Magen-Nativ H, Benyamini N, Cavo M, Larocca A, Takezako N, Suzuki K, Kosugi H, Matsumoto M, Iida S, Ishikawa T, Kondo Y, Sunami K, Ando K, Teshima T, Chou T, Iwasaki H, Miki H, Matsumura I, Onishi Y, Izutsu K, Kizaki M, George A, Blacklock H, Simpson D, Schjesvold F, Waage A, Samoilova O, Nikitin E, Chagorova T, McDonald A, Patel M, Oriol Rocafiguera A, San Miguel Izquierdo J, Mateos M, Streetly M, Forsyth P, Jackson G, Jenkins S, Rifkin R, Yimer H, McCroskey R, Martincic D, Tarantolo S, Larson S, Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 6, pp. 448 - 458 [articolo]
Mateos, Maria-Victoria; Blacklock, Hilary; Schjesvold, Fredrik; Oriol, Albert; Simpson, David; George, Anupkumar; Goldschmidt, Hartmut; Larocca, Alessandra; Chanan-Khan, Asher; Sherbenou, Daniel; Avivi, Irit; Benyamini, Noam; Iida, Shinsuke; Matsumoto, Morio; Suzuki, Kenshi; Ribrag, Vincent; Usmani, Saad Z; Jagannath, Sundar; Ocio, Enrique M; Rodriguez-Otero, Paula; San Miguel, Jesus; Kher, Uma; Farooqui, Mohammed; Liao, Jason; Marinello, Patricia; Lonial, Sagar; KEYNOTE-183 Investigators; Nicol A, Grigoriadis G, Catalano J, LeBlanc R, Elemary M, Bahlis N, Facon T, Karlin L, Ribrag V, Attal M, Goldschmidt H, Engelhardt M, Weisel K, Mackensen A, Nagler A, Ben Yehuda D, Avivi I, Benyamini N, Magen-Nativ H, Palumbo A, Cavo M, Tobinai K, Iida S, Chou T, Suzuki K, Kosugi H, Taniwaki M, Sunami K, Matsumoto M, Ando K, Ganly P, Blacklock H, Simpson D, George A, Schjesvold F, Gjertsen B, Lahuerta J, Blade J, Oriol Rocafiguera A, Mateos M, Rodriguez-Otero P, Larson S, Atanackovic D, Devarakonda, Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 6, pp. 459 - 469 [articolo]
Mateos, Maria-Victoria; Blacklock, Hilary; Schjesvold, Fredrik; Oriol, Albert; Simpson, David; George, Anupkumar; Goldschmidt, Hartmut; Larocca, Alessandra; Chanan-Khan, Asher; Sherbenou, Daniel; Avivi, Irit; Benyamini, Noam; Iida, Shinsuke; Matsumoto, Morio; Suzuki, Kenshi; Ribrag, Vincent; Usmani, Saad Z; Jagannath, Sundar; Ocio, Enrique M; Rodriguez-Otero, Paula; San Miguel, Jesus; Kher, Uma; Farooqui, Mohammed; Liao, Jason; Marinello, Patricia; Lonial, Sagar; KEYNOTE-183 Investigators; Nicol A, Grigoriadis G, Catalano J, LeBlanc R, Elemary M, Bahlis N, Facon T, Karlin L, Ribrag V, Attal M, Goldschmidt H, Engelhardt M, Weisel K, Mackensen A, Nagler A, Ben Yehuda D, Avivi I, Benyamini N, Magen-Nativ H, Palumbo A, Cavo M, Tobinai K, Iida S, Chou T, Suzuki K, Kosugi H, Taniwaki M, Sunami K, Matsumoto M, Ando K, Ganly P, Blacklock H, Simpson D, George A, Schjesvold F, Gjertsen B, Lahuerta J, Blade J, Oriol Rocafiguera A, Mateos M, Rodriguez-Otero P, Larson S, Atanackovic D, Devarakonda, Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 6, pp. 459 - 469 [articolo]
